Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.90
0.00 (0.00%)
At close: Sep 2, 2026

TPEX:7806 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
535.88538.65435.08
Revenue Growth
-23.80%-
Cost of Revenue
392.66374.88296.89
Gross Profit
143.22163.77138.19
Selling, General & Admin
66.8461.0148.71
Research & Development
11.3610.795.25
Other Operating Expenses
0.120.120.13
Operating Expenses
78.4571.9254.09
Operating Income
64.7791.8584.11
Interest Expense
-0.31-2.27-4.86
Interest & Investment Income
0.550.630.61
Other Non Operating Income (Expenses)
4.3451.87
Pretax Income
69.3695.2181.72
Income Tax Expense
13.6619.8714.97
Net Income
55.775.3366.75
Net Income to Common
55.775.3366.75
Net Income Growth
-12.85%-
Shares Outstanding (Basic)
272522
Shares Outstanding (Diluted)
272522
Shares Change
-11.74%-
EPS (Basic)
2.083.053.04
EPS (Diluted)
2.083.043.01
EPS Growth
-1.00%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-188.05-234.66-40.68
Free Cash Flow Per Share
-7.01-9.47-1.83
Gross Margin
26.73%30.40%31.76%
Operating Margin
12.09%17.05%19.33%
Profit Margin
10.39%13.98%15.34%
Free Cash Flow Margin
-35.09%-43.56%-9.35%
EBITDA
104.58130.36111.81
EBITDA Margin
19.52%24.20%25.70%
D&A For EBITDA
39.8138.5227.7
EBIT
64.7791.8584.11
EBIT Margin
12.09%17.05%19.33%
Effective Tax Rate
19.70%20.87%18.32%